References
- AHFS Drug Information Fentanyl Citrate Monograph Bethesda, MD American Society of Health-System Pharmacist 1996 98 1466 1470
- Mock DL Streisand JB Hague B Transmucosal narcotic delivery: an evaluation of fentanyl (lollipop) premedication in man Anesth Analg 1986 65 S102
- Lee M Kern SE Kisicki JC Egan D A pharmacokinetic study to compare two simultaneous 400 μg doses with a single 800 μg dose of oral transmucosal fentanyl citrate J Pain Symptom Manage 2003 26 743 747 12906959
- Zhang H Zhang J Streisand J Oral mucosal drug delivery clinical pharmacokinetics and therapeutic applications Clin Pharmacokinet 2002 41 661 680 12126458
- Lichtor JL Sevarino FB Joshi GP Busch MA Nordbrock E Ginsberg B The relative potency of oral transmucosal fentanyl citrate compared with intravenous morphine in the treatment of moderate to severe postoperative pain Anesth Analg 1999 89 732 738 10475315
- Vasisht N Gever LN Tagarro I Finn AL Single-dose pharmacokinetics of fentanyl buccal soluble film Pain Med 2010 11 1017 1023 20492573
- Reisfield GM Wilson GR Rational use of sublingual opioids in palliative medicine J Palliat Med 2007 10 465 475 17472518
- Überall MA Müller-Schwefe GH Sublingual fentanyl orally disintegrating tablet in daily practice: efficacy, safety and tolerability in patients with breakthrough cancer pain Curr Med Res Opin 2011 27 1385 1394 21561313
- Bredenberg S Duberg M Lennernäs B In vitro and pharmacokinetic evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance Eur J Pharm Sci 2003 20 327 334 14592698
- Lennernas B Hedner T Holmberg M Bredenberg S Nystrom C Lennernas H Pharmacokinetics and tolerability of different doses of fentanyl following sublingual administration of a rapidly dissolving tablet to cancer patients: a new approach to treatment of incident pain Br J Clin Pharmacol 2004 59 249 253 15676050
- Lim CBS Schug SA Sunderland VB Paech JM Liu Y A phase I pharmacokinetic and bioavailability study of a sublingual fentanyl wafer in healthy volunteers Anesth Analg 2012 115 554 559 22584544
- Gardner-Nix J Oral transmucosal fentanyl and sufentanil for incident pain J Pain Symptom Manage 2001 22 627 630 11503630
- British Pharmacopoeia Commission British Pharmacopoeia 2009 London, UK The Stationery Office 2008
- Garsuch V Breitkreutz J Novel analytical methods for the characterization of oral wafers Eur J Pharm Biopharm 2009 73 195 201 19482082
- Boateng JS Matthews KH Auffret AD Humphrey MJ Stevens HNE Eccleston GM In vitro drug release studies of polymeric freeze-dried wafers and solvent-cast films using paracetamol as model soluble drug Int J Pharm 2009 378 66 72 19477255
- Boateng JS Auffret AD Matthews KH Humphrey MJ Stevens HNE Eccleston GM Characterisation of freeze-dried wafers and solvent evaporated films as potential drug delivery system to mucosal surfaces Int J Pharm 2010 389 24 31 20083177
- Abdelbary G Eouani C Prinderre P Joachim J Reynier J Piccerelle P Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration Int J Pharm 2005 292 29 41 15725551
- Darwish M Kirby M Robertson P Tracewell W Jiang JG Absolute and relative bioavailability of fentanyl buccal tablet and oral transmucosal fentanyl citrate J Clin Pharmacol 2007 47 343 350 17322146
- Aronoff G Brennan M Pritchard D Ginsberg B Evidence-based oral transmucosal fentanyl citrate (OTFC) dosing guide lines Pain Med 2005 6 305 314 16083461
- Shojaei A Buccal mucosa as a route for systemic drug delivery J Pharm Sci 1998 1 15 30
- Ghosh TK Pfister WR Drug Delivery to the Oral Cavity Boca Raton, FL CRC Press 2005
- Mercadante S Radbruck L Davies A A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomized, crossover trial Curr Med Res Opin 2009 25 2805 2815 19792837